search
Back to results

Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)

Primary Purpose

Hearing Loss, Cochlear

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
The Microtable® Stereotactic System
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hearing Loss, Cochlear

Eligibility Criteria

22 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female 22 to 80 years of age.
  • Able to complete study related procedures.
  • Able to provide written informed consent.
  • Eligible for cochlear implant surgery as per routine pre-operative CI evaluation/workup. If patient is a candidate for bilateral CI, the research technique will be performed unilaterally on the side with the most favorable anatomy and/or worst residual hearing.
  • Pre-operative CT scan of head/temporal bone as part of routine care showing normal temporal bone and intra-cochlear anatomy.
  • Scheduled to receive either a Cochlear CI522 with the slim straight electrode or a MED-EL Synchrony with standard, Flex 24, or Flex 28 electrode.

Exclusion Criteria:

  • Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing.
  • ASA (American Society of Anesthesiologists) Physical Status classification of 4 or above or determined by surgeon to be too great of a health risk.
  • Previous mastoidectomy on the ear undergoing research procedures.
  • Severe anatomical abnormality of the temporal bone including but not limited to: 1) Mondini malformation 2) common cavity malformation 3) enlarged vestibular aqueducts (EVA) and/or 4) cochlea ossification.
  • Severe chronic ear disease.
  • Active middle ear infection.
  • Subjects without a favorable trajectory based on pre-operative imaging, analysis and planning with favorable trajectory defined as a linear track extending from the surface of the mastoid cortex, through the facial recess, and targeting the basal turn of the cochlea without violation of the external auditory canal, sigmoid sinus, tegmen, and/or facial nerve.

Sites / Locations

  • Medical University of South Carolina

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Visual assessment of electrode insertion

Camera assessment of electrode insertion

Arm Description

This arm will include the first 6 participants. In this group, a cut will be made near the eardrum and it will be lifted up so the surgeon can see the electrode as it goes into the cochlea.

This arm will include the next 6 participants. In this group, a tube with a camera will be inserted past the ear drum, by making a small hole in the ear drum, to see the electrode as it goes into the cochlea.

Outcomes

Primary Outcome Measures

Successful insertion of the CI electrode array into the cochlea.
Assessed by CT confirmation of intra-cochlear placement of the electrode array.

Secondary Outcome Measures

Time in minutes of cochlear implant surgery.
Assessed by physical exam immediately after surgical intervention.
Amount of tissue removed scanning
Volume assessed by comparison of pre-operative CT scan to the post-operative CT scan
Preservation of taste scanning
Assessed by postoperative survey
Optimal electrode position within the cochlea's scala tympani scanning
Assessed by intraoperative CT scan
Avoidance of damage to the facial nerve during the image guided cochlear implantation surgery.
Assessed by physical exam immediately after surgical intervention and follow-up visits via the House-Brackmann scale.

Full Information

First Posted
March 15, 2017
Last Updated
August 22, 2023
Sponsor
Medical University of South Carolina
search

1. Study Identification

Unique Protocol Identification Number
NCT03101917
Brief Title
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
Official Title
Microtable® Microstereotactic Frame and Drill Press and Associated Method for Cochlear Implantation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2024 (Anticipated)
Primary Completion Date
July 5, 2024 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of South Carolina

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The Microtable® Microstereotactic Frame and Drill Press and Associated Method for Cochlear Implantation consists of a patient-customized microstereotactic frame which targets the cochlea. The intended use of the device in this early feasibility study is to surgically access the cochlea, allowing placement of an intra-cochlear electrode array for cochlear implantation, thereby providing a less invasive surgical option than currently performed. Compared to traditional cochlear implantation (CI) surgery, the investigators hypothesize that the minimally invasive, image-guided approach may offer the following benefits: (1) shorter procedure time including shorter general anesthesia time, (2) less tissue removal potentially eliminating post-operative mastoid bone depression, decreased post-operative patient discomfort, and quicker wound healing, (3) better chance of preservation of taste secondary to preservation of the chorda tympani nerve, and (4) standardization of electrode placement potentially allowing more consistent placement within the scala tympani sub-compartment of the cochlea which has been shown to be associated with improved post-operative audiological performance. This early feasibility study will focus on the advantages of the new technology to the patient. Advantages to the healthcare delivery system will be examined during the pivotal study phase.
Detailed Description
The Microtable® Microstereotactic Frame and Drill Press and Associated Method for Cochlear Implantation consists of a patient-customized microstereotactic frame which targets the cochlea. The intended use of the device in this early feasibility study is to surgically access the cochlea, allowing placement of an intra-cochlear electrode array for cochlear implantation, thereby providing a less invasive surgical option than currently performed. Compared to traditional cochlear implantation (CI) surgery, the investigators hypothesize that the minimally invasive, image-guided approach may offer the following benefits: (1) shorter procedure time including shorter general anesthesia time, (2) less tissue removal potentially eliminating post-operative mastoid bone depression, decreased post-operative patient discomfort, and quicker wound healing, (3) better chance of preservation of taste secondary to preservation of the chorda tympani nerve, and (4) standardization of electrode placement potentially allowing more consistent placement within the scala tympani sub-compartment of the cochlea which has been shown to be associated with improved post-operative audiological performance. This early feasibility study will focus on the advantages of the new technology to the patient. Advantages to the healthcare delivery system will be examined during the pivotal study phase. The investigators propose this early feasibility study to determine if minimally invasive image-guided drilling to surgically access the cochlea for CI can be successfully performed. The study will involve only unilateral CI. The decision of unilateral vs. bilateral implantation is made clinically and before the patient may elect to enroll in this study. Bilateral implantation can take place either simultaneously or sequentially, with the decision made by the clinician as part of standard care. If a participant is scheduled for routine bilateral CI, the traditional approach will be used on one side and the investigational approach on the other. Traditional surgery will be performed on the better-hearing ear, and the investigational technique will be performed on the poorer hearing ear. To minimize patient variability, the investigators will only be studying lateral wall electrodes, the Cochlear slim straight electrode and MED-EL electrodes. The investigators plan to enroll 12 cochlear implant patients in two groups. Group 1 will consist of patients implanted under direct visualization afforded by lifting a tympanomeatal flap, and Group 2 will consist of patients implanted with visualization afforded by passing an endoscope across the eardrum via a myringotomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss, Cochlear

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All patients who meet eligibility requirements and choose to participate will undergo the image guided surgical cochlear implantation procedure as described in the protocol.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Visual assessment of electrode insertion
Arm Type
Experimental
Arm Description
This arm will include the first 6 participants. In this group, a cut will be made near the eardrum and it will be lifted up so the surgeon can see the electrode as it goes into the cochlea.
Arm Title
Camera assessment of electrode insertion
Arm Type
Experimental
Arm Description
This arm will include the next 6 participants. In this group, a tube with a camera will be inserted past the ear drum, by making a small hole in the ear drum, to see the electrode as it goes into the cochlea.
Intervention Type
Device
Intervention Name(s)
The Microtable® Stereotactic System
Intervention Description
x
Primary Outcome Measure Information:
Title
Successful insertion of the CI electrode array into the cochlea.
Description
Assessed by CT confirmation of intra-cochlear placement of the electrode array.
Time Frame
Intraoperative
Secondary Outcome Measure Information:
Title
Time in minutes of cochlear implant surgery.
Description
Assessed by physical exam immediately after surgical intervention.
Time Frame
immediately post-operative
Title
Amount of tissue removed scanning
Description
Volume assessed by comparison of pre-operative CT scan to the post-operative CT scan
Time Frame
pre-operative and post-operative
Title
Preservation of taste scanning
Description
Assessed by postoperative survey
Time Frame
2-4 weeks post-operative
Title
Optimal electrode position within the cochlea's scala tympani scanning
Description
Assessed by intraoperative CT scan
Time Frame
Intraoperative
Title
Avoidance of damage to the facial nerve during the image guided cochlear implantation surgery.
Description
Assessed by physical exam immediately after surgical intervention and follow-up visits via the House-Brackmann scale.
Time Frame
up to 12 months post-operative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female 22 to 80 years of age. Able to complete study related procedures. Able to provide written informed consent. Eligible for cochlear implant surgery as per routine pre-operative CI evaluation/workup. If patient is a candidate for bilateral CI, the research technique will be performed unilaterally on the side with the most favorable anatomy and/or worst residual hearing. Pre-operative CT scan of head/temporal bone as part of routine care showing normal temporal bone and intra-cochlear anatomy. Scheduled to receive either a Cochlear CI522 with the slim straight electrode or a MED-EL Synchrony with standard, Flex 24, or Flex 28 electrode. Exclusion Criteria: Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing. ASA (American Society of Anesthesiologists) Physical Status classification of 4 or above or determined by surgeon to be too great of a health risk. Previous mastoidectomy on the ear undergoing research procedures. Severe anatomical abnormality of the temporal bone including but not limited to: 1) Mondini malformation 2) common cavity malformation 3) enlarged vestibular aqueducts (EVA) and/or 4) cochlea ossification. Severe chronic ear disease. Active middle ear infection. Subjects without a favorable trajectory based on pre-operative imaging, analysis and planning with favorable trajectory defined as a linear track extending from the surface of the mastoid cortex, through the facial recess, and targeting the basal turn of the cochlea without violation of the external auditory canal, sigmoid sinus, tegmen, and/or facial nerve.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Robert F. Labadie, MD, PhD
Phone
843-792-7161
Email
labadie@musc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert F. Labadie, MD, PhD
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert F. Labadie, MD, PhD
Phone
843-792-7161
Email
labadie@musc.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)

We'll reach out to this number within 24 hrs